The pharmaceuticals giant AstraZeneca and the charity Cancer Research have inaugurated a new research centre aimed at speeding the creation of cancer drugs.
Functional genomics is a field of molecular biology that seeks to comprehend the functions and interactions of genes and proteins – image courtesy of AstraZeneca. The Functional Genomics Centre – to be located at the Milner Therapeutics Institute on Cambridge’s Biomedical Campus – will reportedly focus on genetic screening, cancer modelling and…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login